Evangeline R. Jackson is a neuro-oncologist based in New Lambton Heights, NSW, Australia. She looks after people facing brain tumour diagnoses, and she also supports families when nervous system conditions affect everyday movement, balance, and wellbeing.
In many cases, patients come with concerns around brain stem tumours, posterior fossa tumours, and different types of glioma. Some situations involve diffuse midline glioma H3 K27M-mutant. Others may relate to gliomatosis cerebri, or more general brain tumour and glioma questions that need careful planning and ongoing follow-up.
There are also conditions where symptoms can be linked to nerve and blood vessel changes. For example, telangiectasia and ataxia-telangiectasia can cause problems with co-ordination and walking, and they may come with a lot of uncertainty for patients and carers. Having a clinician who understands both the brain side and the day-to-day impact can make a real difference while decisions are being made.
At times, care can extend beyond the brain symptoms too. Some people are dealing with fertility and reproduction issues, and infertility is one of the conditions listed in her service scope. That can be a sensitive topic, and it often needs clear, practical guidance alongside medical planning.
Neuro-oncology work can involve long stretches of appointments, scans, and treatment discussions. It may also include symptom support, so patients can feel as comfortable as possible while treatment plans are working out. Because each case is different, the focus is on getting the details right and supporting families through what can be a stressful journey.
Information about Evangeline’s work experience is not listed here. The same goes for education details, including any degree or training information. If you need those specifics, it may help to check directly with the practice.
Research and clinical trials are not listed in the available information. If you’re interested in whether clinical trials are an option for a particular diagnosis, it’s best to ask about current trial pathways during a consultation.